Method of treating ulcerative colitis and Crohn's disease using IL-17 receptor proteins
US7005412B1 · kind B1 · utility
1Cited by
3References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 20, 2000 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Jan 20, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for regulating levels of nitric oxide are disclosed. The methods utilize IL-17 receptors, which may be used in conjunction with inhibitor IL-1 and/or TNF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.